Stay updated on Belantamab vs Bortezomib in MM Clinical Trial

Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision: v3.6.4 is now shown, replacing v3.6.3. This reflects a platform release update and does not modify the study content.
    Difference
    0.0%
    Check dated 2026-07-25T16:59:11.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The page no longer displays the 'Multiple myeloma' disease label, the 'related topics:' header, and the MedlinePlus Genetics link. This reduces visible disease context and related resource references for users.
    Difference
    0.1%
    Check dated 2026-07-18T14:42:26.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    This change adds a 'Multiple myeloma' topic tag and a 'related topics' section linking to MedlinePlus Genetics, providing additional context and resources related to the study's disease area.
    Difference
    0.1%
    Check dated 2026-07-11T14:24:48.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A new revision (v3.6.3) was added, replacing the previous revision (v3.6.2), indicating a small platform update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-07-04T09:18:04.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.6.2 is now shown on the page, and the items 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and 'Revision: v3.6.0' were removed.
    Difference
    0.1%
    Check dated 2026-06-27T05:39:06.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Recruitment status updated to no longer recruit participants, and the locations section expanded to 122 sites with new entries in China, Brazil, and New Zealand. The page also added guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and included the sponsor's data-sharing policy.
    Difference
    0.9%
    Check dated 2026-06-12T23:58:25.000Z thumbnail image

Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.